DEUTSCHE BANK AG\ - INNOVAGE HLDG CORP ownership

INNOVAGE HLDG CORP's ticker is INNV and the CUSIP is 45784A104. A total of 60 filers reported holding INNOVAGE HLDG CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of INNOVAGE HLDG CORP
ValueSharesWeighting
Q3 2023$58,672
-20.1%
9,7950.0%0.00%
Q2 2023$73,463
-27.1%
9,795
-22.4%
0.00%
Q1 2023$100,779
+67.9%
12,629
+51.0%
0.00%
Q4 2022$60,032
+22.5%
8,361
+1.5%
0.00%
Q3 2022$49,000
+16.7%
8,235
-13.5%
0.00%
Q2 2022$42,000
-39.1%
9,518
-11.7%
0.00%
Q1 2022$69,000
+15.0%
10,777
-9.9%
0.00%
Q4 2021$60,000
-94.4%
11,955
-92.6%
0.00%
-100.0%
Q3 2021$1,065,000
-69.0%
161,130
-0.2%
0.00%
-50.0%
Q2 2021$3,440,000161,4660.00%
Other shareholders
INNOVAGE HLDG CORP shareholders Q1 2022
NameSharesValueWeighting ↓
COURAGE CAPITAL MANAGEMENT LLC 207,000$5,339,0003.90%
Monashee Investment Management LLC 250,000$6,448,0000.99%
SECTORAL ASSET MANAGEMENT INC 479,794$12,374,0000.94%
INHERENT GROUP, LP 231,214$5,963,0000.84%
Sivik Global Healthcare LLC 85,000$2,192,0000.80%
Camber Capital Management LP 650,000$16,764,0000.58%
PFM Health Sciences, LP 429,699$11,082,0000.34%
Redmile Group, LLC 850,000$21,922,0000.31%
HealthCor Management, L.P. 325,000$8,382,0000.30%
Rock Springs Capital Management LP 475,000$12,250,0000.27%
View complete list of INNOVAGE HLDG CORP shareholders